Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies

被引:72
作者
Lorenz, P
Baker, BF
Bennett, CF
Spector, DL
机构
[1] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[2] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
D O I
10.1091/mbc.9.5.1007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antisense oligonucleotides are powerful tools for the in vivo regulation of gene expression. We have characterized the intracellular distribution of fluorescently tagged phosphorothioate oligodeoxynucleotides (PS-ONs) at high resolution under conditions in which PS-ONs have the potential to display antisense activity. Under these conditions PS-ONs predominantly localized to the cell nucleus where they accumulated in 20-30 bright spherical foci designated phosphorothioate bodies (PS bodies), which were set against a diffuse nucleoplasmic population excluding nucleoli. PS bodies are nuclear structures that formed in cells after PS-ON delivery by transfection agents or microinjection but were observed irrespectively of antisense activity or sequence. Ultrastructurally, PS bodies corresponded to electron-dense structures of 150-300 nm diameter and resembled nuclear bodies that were found with lower frequency in cells lacking PS-ONs. The environment of a living cell was required for the de novo formation of PS bodies, which occurred within minutes after the introduction of PS-ONs. PS bodies were stable entities that underwent noticeable reorganization only during mitosis. Upon exit from mitosis, PS bodies were assembled de novo from diffuse PS-ON pools in the daughter nuclei. In situ fractionation demonstrated an association of PS-ONs with the nuclear matrix. Taken together, our data provide evidence for the formation of a nuclear body in cells after introduction of phosphorothioate oligodeoxynucleotides.
引用
收藏
页码:1007 / 1023
页数:17
相关论文
共 73 条
[71]   ANTISENSE GENE INHIBITION BY OLIGONUCLEOTIDES CONTAINING C-5 PROPYNE PYRIMIDINES [J].
WAGNER, RW ;
MATTEUCCI, MD ;
LEWIS, JG ;
GUTIERREZ, AJ ;
MOULDS, C ;
FROEHLER, BC .
SCIENCE, 1993, 260 (5113) :1510-1513
[72]   BCL-2 antisense therapy in patients with non-Hodgkin lymphoma [J].
Webb, A ;
Cunningham, D ;
Cotter, F ;
Clarke, PA ;
diStefano, F ;
Ross, P ;
Corbo, M ;
Dziewanowska, Z .
LANCET, 1997, 349 (9059) :1137-1141
[73]   PHOSPHOROTHIOATE OLIGONUCLEOTIDES BIND IN A NON SEQUENCE-SPECIFIC MANNER TO THE NUCLEOLAR PROTEIN C23/NUCLEOLIN [J].
WEIDNER, DA ;
VALDEZ, BC ;
HENNING, D ;
GREENBERG, S ;
BUSCH, H .
FEBS LETTERS, 1995, 366 (2-3) :146-150